Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H27N3O |
| Molecular Weight | 349.4693 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)[C@H]1CN(CC=C)[C@@H]2CC3=CNC4=C3C(=CC=C4)C2=C1
InChI
InChIKey=JCQLEPDZFXGHHQ-OXQOHEQNSA-N
InChI=1S/C22H27N3O/c1-4-10-25-14-16(22(26)24(5-2)6-3)11-18-17-8-7-9-19-21(17)15(13-23-19)12-20(18)25/h4,7-9,11,13,16,20,23H,1,5-6,10,12,14H2,2-3H3/t16-,20-/m1/s1
| Molecular Formula | C22H27N3O |
| Molecular Weight | 349.4693 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:07:39 GMT 2025
by
admin
on
Mon Mar 31 23:07:39 GMT 2025
|
| Record UNII |
020O2SR91L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
TiHKAL
Created by
admin on Mon Mar 31 23:07:39 GMT 2025 , Edited by admin on Mon Mar 31 23:07:39 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-AL-LAD
Created by
admin on Mon Mar 31 23:07:39 GMT 2025 , Edited by admin on Mon Mar 31 23:07:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
AL-LAD
Created by
admin on Mon Mar 31 23:07:39 GMT 2025 , Edited by admin on Mon Mar 31 23:07:39 GMT 2025
|
PRIMARY | AL-LAD, also known as 6-allyl-6-nor-LSD, is a psychedelic drug and an analog of lysergic acid diethylamide (LSD). It is described by Alexander Shulgin in the book TiHKAL (Tryptamines i Have Known And Loved). It is synthesized starting from LSD as a precursor, using allyl bromide as a reactant. | ||
|
DTXSID30215822
Created by
admin on Mon Mar 31 23:07:39 GMT 2025 , Edited by admin on Mon Mar 31 23:07:39 GMT 2025
|
PRIMARY | |||
|
15227511
Created by
admin on Mon Mar 31 23:07:39 GMT 2025 , Edited by admin on Mon Mar 31 23:07:39 GMT 2025
|
PRIMARY | |||
|
020O2SR91L
Created by
admin on Mon Mar 31 23:07:39 GMT 2025 , Edited by admin on Mon Mar 31 23:07:39 GMT 2025
|
PRIMARY | |||
|
65527-61-9
Created by
admin on Mon Mar 31 23:07:39 GMT 2025 , Edited by admin on Mon Mar 31 23:07:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
